Aging Populations And Emerging Markets Will Transform Pharmaceutical Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
10 Aug 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
₹1,338.64
25.8% undervalued intrinsic discount15 Aug
₹992.95
1Y
-8.4%7D
4.8%